These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 30145593)
1. Expression Levels of Follicle-Stimulating Hormone Receptor and Implication in Diagnostic and Therapeutic Strategy of Ovarian Cancer. Wei S; Lai L; Yang J; Zhuandi G Oncol Res Treat; 2018; 41(10):651-654. PubMed ID: 30145593 [TBL] [Abstract][Full Text] [Related]
2. FSH receptor binding inhibitor restrains follicular development and possibly attenuates carcinogenesis of ovarian cancer through down-regulating expression levels of FSHR and ERβ in normal ovarian tissues. Zhuandi G; Tuanjie C; Luju L; Abdiryim A; Yingying D; Haoqin L; Suocheng W; Li D Gene; 2018 Aug; 668():174-181. PubMed ID: 29783074 [TBL] [Abstract][Full Text] [Related]
4. Role of nerve growth factor and FSH receptor in epithelial ovarian cancer. Bose CK Reprod Biomed Online; 2005 Aug; 11(2):194-7. PubMed ID: 16168216 [TBL] [Abstract][Full Text] [Related]
5. Genetic variations altering FSH action affect circulating hormone levels as well as follicle growth in healthy peripubertal girls. Busch AS; Hagen CP; Almstrup K; Main KM; Juul A Hum Reprod; 2016 Apr; 31(4):897-904. PubMed ID: 26905078 [TBL] [Abstract][Full Text] [Related]
6. Follicle-stimulating hormone induced epithelial-mesenchymal transition of epithelial ovarian cancer cells through follicle-stimulating hormone receptor PI3K/Akt-Snail signaling pathway. Yang Y; Zhang J; Zhu Y; Zhang Z; Sun H; Feng Y Int J Gynecol Cancer; 2014 Nov; 24(9):1564-74. PubMed ID: 25340291 [TBL] [Abstract][Full Text] [Related]
7. Follicle-Stimulating Hormone Receptor as a Target in the Redirected T-cell Therapy for Cancer. Urbanska K; Stashwick C; Poussin M; Powell DJ Cancer Immunol Res; 2015 Oct; 3(10):1130-7. PubMed ID: 26112923 [TBL] [Abstract][Full Text] [Related]
8. Follicle-Stimulating Hormone Receptor Is Expressed by Most Ovarian Cancer Subtypes and Is a Safe and Effective Immunotherapeutic Target. Perales-Puchalt A; Svoronos N; Rutkowski MR; Allegrezza MJ; Tesone AJ; Payne KK; Wickramasinghe J; Nguyen JM; O'Brien SW; Gumireddy K; Huang Q; Cadungog MG; Connolly DC; Tchou J; Curiel TJ; Conejo-Garcia JR Clin Cancer Res; 2017 Jan; 23(2):441-453. PubMed ID: 27435394 [TBL] [Abstract][Full Text] [Related]
9. Quantitative analysis of follicle-stimulating hormone receptor in ovarian epithelial tumors: a novel approach to explain the field effect of ovarian cancer development in secondary mullerian systems. Wang J; Lin L; Parkash V; Schwartz PE; Lauchlan SC; Zheng W Int J Cancer; 2003 Jan; 103(3):328-34. PubMed ID: 12471615 [TBL] [Abstract][Full Text] [Related]
10. Follicle-Stimulating Hormone Receptor (FSHR): A Promising Tool in Oncology? Papadimitriou K; Kountourakis P; Kottorou AE; Antonacopoulou AG; Rolfo C; Peeters M; Kalofonos HP Mol Diagn Ther; 2016 Dec; 20(6):523-530. PubMed ID: 27392476 [TBL] [Abstract][Full Text] [Related]
11. Ovarian epithelial tumor growth promotion by follicle-stimulating hormone and inhibition of the effect by luteinizing hormone. Zheng W; Lu JJ; Luo F; Zheng Y; Feng Yj; Felix JC; Lauchlan SC; Pike MC Gynecol Oncol; 2000 Jan; 76(1):80-8. PubMed ID: 10620446 [TBL] [Abstract][Full Text] [Related]
12. Expression and actions of both the follicle stimulating hormone receptor and the luteinizing hormone receptor in normal ovarian surface epithelium and ovarian cancer. Parrott JA; Doraiswamy V; Kim G; Mosher R; Skinner MK Mol Cell Endocrinol; 2001 Feb; 172(1-2):213-22. PubMed ID: 11165055 [TBL] [Abstract][Full Text] [Related]
14. Reduced Gonadotrophin Receptor Expression Is Associated with a More Aggressive Ovarian Cancer Phenotype. Cheung J; Lokman NA; Abraham RD; Macpherson AM; Lee E; Grutzner F; Ghinea N; Oehler MK; Ricciardelli C Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374698 [TBL] [Abstract][Full Text] [Related]
15. Engineered DNA Vaccination against Follicle-Stimulating Hormone Receptor Delays Ovarian Cancer Progression in Animal Models. Perales-Puchalt A; Wojtak K; Duperret EK; Yang X; Slager AM; Yan J; Muthumani K; Montaner LJ; Weiner DB Mol Ther; 2019 Feb; 27(2):314-325. PubMed ID: 30554854 [TBL] [Abstract][Full Text] [Related]
16. Follicle-stimulating hormone receptor is expressed in human ovarian surface epithelium and fallopian tube. Zheng W; Magid MS; Kramer EE; Chen YT Am J Pathol; 1996 Jan; 148(1):47-53. PubMed ID: 8546225 [TBL] [Abstract][Full Text] [Related]
17. Poor ovarian response to gonadotropin stimulation is associated with low expression of follicle-stimulating hormone receptor in granulosa cells. Cai J; Lou HY; Dong MY; Lu XE; Zhu YM; Gao HJ; Huang HF Fertil Steril; 2007 Jun; 87(6):1350-6. PubMed ID: 17296182 [TBL] [Abstract][Full Text] [Related]
18. Follicle stimulating hormone receptor (FSHR) antagonist and epithelial ovarian cancer (EOC). Bose CK J Exp Ther Oncol; 2007; 6(3):201-4. PubMed ID: 17552360 [TBL] [Abstract][Full Text] [Related]
19. Follicle stimulating hormone receptor in ovarian surface epithelium and epithelial ovarian cancer. Bose CK Oncol Res; 2008; 17(5):231-8. PubMed ID: 18980020 [TBL] [Abstract][Full Text] [Related]
20. A role for neurotransmitters in early follicular development: induction of functional follicle-stimulating hormone receptors in newly formed follicles of the rat ovary. Mayerhofer A; Dissen GA; Costa ME; Ojeda SR Endocrinology; 1997 Aug; 138(8):3320-9. PubMed ID: 9231784 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]